A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92.
Becerra, Carlos R
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Nov 2013 - 1425-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3182a46c3b doi
Adenocarcinoma--pathology
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Squamous Cell--pathology
Cetuximab
Combined Modality Therapy
Esophageal Neoplasms--pathology
Esophagectomy
Esophagogastric Junction--pathology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Radiotherapy Dosage
Remission Induction
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Nov 2013 - 1425-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3182a46c3b doi
Adenocarcinoma--pathology
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Agents--therapeutic use
Carcinoma, Squamous Cell--pathology
Cetuximab
Combined Modality Therapy
Esophageal Neoplasms--pathology
Esophagectomy
Esophagogastric Junction--pathology
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Radiotherapy Dosage
Remission Induction